2543-95-5 Usage
Uses
Used in Pharmaceutical Industry:
(S)-4-Methoxydalbergione is used as an antioxidant agent for its potential to protect cells from oxidative damage, which is a significant factor in various diseases and aging processes.
(S)-4-Methoxydalbergione is used as an anticancer agent for its potential to inhibit the growth and proliferation of cancer cells, making it a candidate for further research in cancer treatment.
Used in Enzyme Inhibition:
(S)-4-Methoxydalbergione is used as an enzyme inhibitor for its ability to inhibit the activity of certain enzymes, which can be beneficial in the development of drugs targeting specific enzymatic pathways.
Used in Dye Production:
(S)-4-Methoxydalbergione is used as a chemical intermediate in the production of colored dyes, due to its potential to contribute to the coloration of various materials.
Used in Organic Synthesis:
(S)-4-Methoxydalbergione is used as a chemical intermediate in organic synthesis, allowing for the creation of new compounds with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 2543-95-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,4 and 3 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2543-95:
(6*2)+(5*5)+(4*4)+(3*3)+(2*9)+(1*5)=85
85 % 10 = 5
So 2543-95-5 is a valid CAS Registry Number.
2543-95-5Relevant academic research and scientific papers
Enantioselective addition of boronates to o -quinone methides catalyzed by chiral biphenols
Luan, Yi,Schaus, Scott E.
, p. 19965 - 19968 (2013/02/22)
Chiral biphenols were found to catalyze the enantioselective asymmetric addition of aryl- or alkenylboronates to o-quinone methides. Substituted 2-styryl phenols were obtained in good yields (up to 95%) with high enantiomeric ratios (up to 98:2) in the pr
Stereoselective synthesis of (R)- and (S)-4-methoxydalbergione via asymmetric catalytic hydrogenation
Bissel, Philippe,Nazih, Abdesslame,Sablong, Rafael,Lepoittevin, Jean-Pierre
, p. 1283 - 1285 (2008/02/09)
(Matrix presented) (R)-(+)-and (S)-(-)-4-methoxydalbergione were synthesized in seven steps with an enantiomeric excess of up to 95% using an asymmetric catalytic hydrogenation step with [Rh((S,S)-bdpp)(NBD)]CIO4 or [Rh((R,R)-bdpp)(NBD)]CIOsub
